ABSI NASDAQ
Absci Corporation
1W: +10.7%
1M: -3.0%
3M: +32.5%
YTD: +161.8%
1Y: +120.8%
3Y: +605.2%
5Y: -13.4%
$10.57
+1.12 (+11.85%)
After Hours: $10.43 (-0.14, -1.37%)
Weekly Expected Move ±15.2%
$6
$8
$9
$11
$12
Credit Risk of going bust: lower than 61% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Absci Corporation would be worth roughly what it owes.
Total debt $3.7M against a stock market value of $1.62B.
Distance to default 6.31 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 100.4%; Altman Z'' 4.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Absci Corporation would be worth roughly what it owes.
Total debt $3.7M against a stock market value of $1.62B.
Distance to default 6.31 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 100.4%; Altman Z'' 4.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.30
Neutral
1 bullish
2 neutral
0 bearish
Articles (24h)
3
Hourly Sentiment (24h)
0.45
Bullish
3 bullish
3 neutral
0 bearish
Articles (7d)
6
Daily Sentiment (7 Days)
Articles (100)
Absci to Participate in Upcoming Investor Conferences - Yahoo Finance
Absci to Participate in Upcoming Investor Conferences
Absci (NASDAQ:ABSI) Stock Crosses Above 50-Day Moving Average - Here's Why - MarketBeat
How Investors Are Reacting To Absci (ABSI) Early Hair Loss Trial Data - Simply Wall Street
Is Absci (ABSI) Undervalued As Positive ABS 201 Phase 1 Data Lifts Optimism?
ABSI Oct 2026 9.000 put (ABSI261016P00009000) stock historical prices and data - Yahoo Finance UK
Absci (NASDAQ:ABSI) Stock Price Up 5.8% After Analyst Upgrade
ABSI May 2027 15.000 call (ABSI270521C00015000) stock price, news, quote and history - Yahoo Finance Singapore
Absci (NASDAQ:ABSI) Shares Climb 5.8% Following Analyst Upgrade - MarketBeat
ABSI Jan 2029 10.000 call (ABSI290119C00010000) stock price, news, quote and history - Yahoo Finance Singapore
ABSI Jan 2027 6.000 put (ABSI270115P00006000) interactive stock chart - Yahoo Finance UK
How ABSI Corporation (ABSI) Affects Rotational Strategy Timing - Stock Traders Daily
ABSI Jan 2027 10.000 put (ABSI270115P00010000) stock historical prices and data - Yahoo Finance UK
ABSI Jan 2027 10.000 put (ABSI270115P00010000) interactive stock chart - Yahoo Finance UK
ABSI Jan 2027 10.000 put (ABSI270115P00010000) stock price, news, quote and history - Yahoo Finance UK
Absci (ABSI) Stock Seems Rich Against Its Book Value Backdrop - Yahoo Finance
Absci (ABSI) Stock Seems Rich Against Its Book Value Backdrop
Absci (NASDAQ:ABSI) Stock Gets Price Target Boost from KeyCorp - MarketBeat
Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026
Absci (NASDAQ:ABSI) Stock Rating Reaffirmed as Buy by HC Wainwright - MarketBeat
Absci (NASDAQ:ABSI) Stock Price Target Raised at JPMorgan Chase & Co. - MarketBeat
Absci (NASDAQ:ABSI) Stock Price Up 13.2% – Here’s Why
ABSI Jan 2027 10.000 call (ABSI270115C00010000) stock historical prices and data - Yahoo Finance UK
Absci (NASDAQ:ABSI) Stock Jumps 13.2% - Still a Buy? - MarketBeat
ABSI Oct 2026 14.000 call (ABSI261016C00014000) stock price, news, quote and history - Yahoo Finance UK
Absci Corporation (ABSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Absci (ABSI) Stock Dropped, So What Is Behind The Latest Attention? - Yahoo Finance
Absci (ABSI) Stock Dropped, So What Is Behind The Latest Attention?
ABSI Oct 2026 9.000 put (ABSI261016P00009000) stock price, news, quote and history - Yahoo Finance UK
Trading the Move, Not the Narrative: (ABSI) Edition - Stock Traders Daily
ABSI Oct 2026 13.000 call (ABSI261016C00013000) stock historical prices and data - Yahoo Finance UK
Is Absci (ABSI) A Bargain On Its ABS 201 Phase 2 Trial Update? - Simply Wall Street
ABSI Feb 2027 6.000 call (ABSI270219C00006000) interactive stock chart - Yahoo Finance UK
ABSI Jan 2028 10.000 call (ABSI280121C00010000) stock historical prices and data - Yahoo Finance UK
Absci (NASDAQ:ABSI) Shares Down 5.5% - Here's Why - MarketBeat
Insiders See US$933.2k Investment In Absci Jump Last Week - Moomoo
ABSI Nov 2026 17.000 call (ABSI261120C00017000) Stock Historical Prices & Data - Yahoo! Finance Canada
ABSI Nov 2026 4.000 call (ABSI261120C00004000) interactive stock chart - Yahoo Finance Australia
Phase 2 Trial Plans Could Be A Game Changer For Absci Stock (ABSI) - Simply Wall Street
ABSI Oct 2026 9.000 call (ABSI261016C00009000) interactive stock chart - Yahoo Finance UK
Absci Corporation (NASDAQ:ABSI) Stock Has Average Target Price of $13.71 - MarketBeat
Absci Corporation (NASDAQ:ABSI) Stock Has Average Target Price of $13.71
ABSI Jan 2027 5.000 put (ABSI270115P00005000) stock price, news, quote and history - Yahoo Finance UK
Absci (NASDAQ:ABSI) Stock Jumps 6.1% - Still a Buy? - MarketBeat
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
Endometriosis affects roughly 1 in 10 women of reproductive age. Absci plans a drug trial in about 150 patients. - Stock Titan
Absci (NASDAQ:ABSI) Stock Price Down 8.3% - What's Next? - MarketBeat
Novo eyes hair-loss market as Ozempic maker looks to diversify
Absci (ABSI) Stock Looks Expensive Against Its Book Value
Absci (ABSI) Stock Looks Expensive Against Its Book Value - Yahoo Finance
Recursion Pharmaceuticals Highlights AI Drug Platform, FAP Progress at Morgan Stanley Conference
10 small-cap healthcare stocks with the strongest momentum grades
Absci (NASDAQ:ABSI) Stock Price Up 12.5% - Here's What Happened - MarketBeat
The Technical Signals Behind (ABSI) That Institutions Follow - news.stocktradersdaily.com
Squarepoint Ops LLC Sells 228,841 Shares of Absci Corporation $ABSI - MarketBeat
PASG Stock Slumps 16% After-Hours — What’s Driving The Selloff? - Stocktwits
Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic
Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic - Yahoo Finance
Absci (ABSI) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
$ABSI stock is down 3% today. Here's what we see in our data. - Quiver Quantitative
FDA names acting heads of drug and vaccine units to permanent roles
Bank of New York Mellon Corp Buys Shares of 386,832 Absci Corporation $ABSI
Absci Corporation Stock (ABSI) Opinions on Investor Conference Participation - Quiver Quantitative
Absci Corporation $ABSI Shares Bought by Bank of America Corp DE
Can Absci’s (ABSI) Low-Frequency Hair Loss Therapy Redefine Its Long-Term Platform Potential? - simplywall.st
Absci to Participate in Upcoming Investor Conferences
Hair Loss Biotechs Emerge As Wall Street's Newest Growth Trade
Biotech Breakout: What's in focus after Moderna's cancer win?
Biotechs hit a post-pandemic high after mRNA trial win for Moderna, Merck
Absci (ABSI) Q2 2026 Earnings Call Transcript
Absci (ABSI) Q2 2026 Earnings Call Transcript
$ABSI stock is up 11% today. Here's what we see in our data. - Quiver Quantitative
AMD’s $1.3 Billion Portfolio Reveals Its Biggest Investments and Where AI Demand Lands Next
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma
Recursion Pharmaceuticals Highlights AI Platform, Roche Progress and Pipeline Updates
Dimensional Fund Advisors LP Cuts Position in Absci Corporation $ABSI
Absci (ABSI) On Early ABS 201 Data And Lilly Deal That Could Support Its Valuation
Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed?
Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed? - Yahoo Finance
Absci Corporation Q2 2026 Earnings Call Summary
Absci Q2 Earnings Call Highlights
Absci Corporation (NASDAQ: ABSI) boosts cash to $201M while net loss deepens - Stock Titan
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
Recursion Pharmaceuticals Q2 Earnings Call Highlights
Are Medical Stocks Lagging ABSCI CORP (ABSI) This Year?
Are Medical Stocks Lagging ABSCI CORP (ABSI) This Year?
Are Medical Stocks Lagging ABSCI CORP (ABSI) This Year? - Yahoo Finance
Viking Therapeutics to Report Q2 Earnings: What's in Store for the Stock?
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
Absci sets 4:30 p.m. ET webcast for its Aug. 11 Q2 update - Stock Titan
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026
Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Know - Yahoo Finance
Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Know
Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Know
$ABSI stock is down 9% today. Here's what we see in our data. - Quiver Quantitative
Here's Why Absci Corporation (ABSI) is a Great Momentum Stock to Buy